Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[A retrospective study of kidney insufficiency in adult patients after myeloablative allogeneic hematopoietic stem cell transplantation].

Luo CW, DU X, Weng JY, Wu SJ, Guo R, Lu ZS, Ling W.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):671-5. Chinese.

PMID:
22739180
2.

Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.

Yu ZP, Ding JH, Chen BA, Liu BC, Liu H, Li YF, Ding BH, Qian J.

Chin J Cancer. 2010 Nov;29(11):946-51.

3.

Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation.

Ileri T, Ertem M, Ozcakar ZB, Ince EU, Biyikli Z, Uysal Z, Ekim M, Yalcinkaya F.

Pediatr Transplant. 2010 Feb;14(1):138-44. doi: 10.1111/j.1399-3046.2009.01182.x. Epub 2009 Apr 6.

PMID:
19413721
4.

[Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].

Zhou T, Cen XN, Qiu ZX, Ou JP, Wang WS, Xu WL, Li Y, Wang MJ, Wang LH, Tong YJ, Ren HY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):723-8. Chinese.

PMID:
19549395
5.

[Clinical study on acute kidney injury after myeloablative allogeneic hematopoietic cell transplantation].

Bao YS, Jiang EL, Wang M, Huang Y, Wei JL, Yang DL, Feng SZ, Han MZ.

Zhonghua Xue Ye Xue Za Zhi. 2008 Jun;29(6):401-4. Chinese.

PMID:
19031744
6.

Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation.

Caliskan Y, Besisik SK, Sargin D, Ecder T.

Bone Marrow Transplant. 2006 Jul;38(2):141-7. Epub 2006 Jun 12.

PMID:
16770317
7.

An evaluation of the RIFLE criteria for acute kidney injury after myeloablative allogeneic haematopoietic stem cell transplantation.

Bao YS, Xie RJ, Wang M, Feng SZ, Han MZ.

Swiss Med Wkly. 2011 Jul 18;141:w13225. doi: 10.4414/smw.2011.13225.

8.

Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation.

Oshima K, Kanda Y, Nanya Y, Tanaka M, Nakaseko C, Yano S, Fujisawa S, Fujita H, Yokota A, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy.

Ann Hematol. 2013 Jan;92(2):255-60. doi: 10.1007/s00277-012-1584-1. Epub 2012 Oct 4.

PMID:
23053182
9.

Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.

Fraile P, Vazquez L, Caballero D, Garcia-Cosmes P, López L, San Miguel J, Tabernero JM.

Eur J Haematol. 2013 Aug;91(2):129-34. doi: 10.1111/ejh.12149. Epub 2013 Jun 28. Erratum in: Eur J Haematol. 2013 Oct;91(4):380. Pilar, Fraile [corrected to Fraile, Pilar]; Lourdes, Vazquez [corrected to Vazquez, Lourdes]; Dolores, Caballero [corrected to Caballero, Dolores]; Pedro, Garcia-Cosmes [corrected to Garcia-Cosmes, Pedro]; Lucia, López [corrected to López, Lucia]; Jesus, San Miguel [corrected to San Miguel, Jesus]; Jose Matias, Tabernero [corrected to Tabernero, Jose Matias].

PMID:
23710658
10.

Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria.

Mori J, Ohashi K, Yamaguchi T, Ando M, Hirashima Y, Kobayashi T, Kakihana K, Sakamaki H.

Intern Med. 2012;51(16):2105-10. Epub 2012 Aug 15.

11.

[Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].

Ma X, Wu DP, Sun AN, Fu ZZ, Tang XW, Wu XJ, Liu YJ, Qiu HY, Miao M, Han Y, Jin ZM, Zhao Y, Xue SL, Wang Y, Chen SN, He GS, Zhou HX, Chang HR.

Zhonghua Xue Ye Xue Za Zhi. 2009 Feb;30(2):73-6. Chinese.

PMID:
19563014
12.

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.

Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

13.

Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience.

Kang SH, Park HS, Sun IO, Choi SR, Chung BH, Choi BS, Min CK, Do JY, Yang CW, Kim YS, Yoon KW, Park CW.

Clin Nephrol. 2012 Mar;77(3):225-30.

PMID:
22377254
14.

Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells.

Tokgoz B, Kocyigit I, Polat G, Eser B, Unal A, Kaynar L, Sipahioglu MH, Oymak O, Utas C, Cetin M.

Ren Fail. 2010 Jun;32(5):547-54. doi: 10.3109/08860221003728721.

PMID:
20486836
15.

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.

Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M.

Am J Hematol. 2006 Jul;81(7):525-31.

16.

Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.

Radhakrishnan K, Bishop J, Jin Z, Kothari K, Bhatia M, George D, Garvin JH Jr, Martinez M, Ovchinsky N, Lobritto S, Elsayed Y, Satwani P.

Biol Blood Marrow Transplant. 2013 Jun;19(6):912-7. doi: 10.1016/j.bbmt.2013.02.019. Epub 2013 Mar 1.

17.

[Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].

Chen X, Wei JL, Huang Y, He Y, Yang DL, Jiang EL, Ma QL, Zhou LK, Lin XT, Shen YY, Feng SZ, Han MZ.

Zhonghua Xue Ye Xue Za Zhi. 2012 Aug;33(8):610-4. Chinese.

PMID:
23134851
18.

[Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].

Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP.

Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3062-6. Chinese.

PMID:
16324408
19.

[Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].

Chen L, Luo Y, Hu Y, Tan Y, Zhao Y, Fan J, Huang H.

Zhonghua Yi Xue Za Zhi. 2014 Nov 4;94(40):3145-9. Chinese.

PMID:
25573309
20.

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.

Liu J, Kong J, Chang YJ, Chen H, Chen YH, Han W, Wang Y, Yan CH, Wang JZ, Wang FR, Chen Y, Zhang XH, Xu LP, Liu KY, Huang XJ.

Clin Microbiol Infect. 2015 Dec;21(12):1121.e9-15. doi: 10.1016/j.cmi.2015.06.009. Epub 2015 Jun 17.

Supplemental Content

Support Center